LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Alpelisib | 0.031667 | 81.20 | 770.25 | 12683 | 11766 | 1.0779 | 1.0385 | MN20160304_L02 | M19 |
| MCF 10A-H2B-mCherry | 0 | 87.14 | 771.67 | 12687 | 12592 | 1.0075 | 1.0037 | MN20160304_L01 | D21 | |
| MCF 10A-H2B-mCherry | Alpelisib | 0.01 | 74.50 | 770.25 | 12687 | 10991 | 1.1542 | 1.0762 | MN20160304_L02 | J15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.69 | 771.67 | 12690 | 11974 | 1.0598 | 1.0296 | MN20160304_L01 | E21 |
| MCF 10A-H2B-mCherry | 0 | 84.92 | 771.67 | 12701 | 12266 | 1.0354 | 1.0175 | MN20160304_L01 | K09 | |
| MCF 10A-H2B-mCherry | Alpelisib | 0.1 | 84.92 | 771.67 | 12701 | 12266 | 1.0354 | 1.0175 | MN20160304_L01 | M16 |
| MCF 10A-H2B-mCherry | Taxol | 0.00013333 | 85.64 | 770.25 | 12702 | 12287 | 1.0337 | 1.0167 | MN20160304_L02 | N19 |
| MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 74.50 | 770.25 | 12703 | 10991 | 1.1557 | 1.0769 | MN20160304_L02 | L12 |
| MCF 10A-H2B-mCherry | 0 | 85.64 | 770.25 | 12705 | 12287 | 1.0340 | 1.0168 | MN20160304_L02 | H10 | |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 85.64 | 770.25 | 12706 | 12287 | 1.0341 | 1.0168 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 84.92 | 771.67 | 12713 | 12266 | 1.0364 | 1.0180 | MN20160304_L01 | N17 |
| MCF 10A-H2B-mCherry | Taxol | 0.00033333 | 87.86 | 770.25 | 12719 | 12543 | 1.0140 | 1.0069 | MN20160304_L02 | E11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 87.14 | 771.67 | 12725 | 12592 | 1.0105 | 1.0052 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.17783 | 82.69 | 771.67 | 12725 | 11974 | 1.0627 | 1.0310 | MN20160304_L01 | E12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.76 | 771.67 | 12726 | 10851 | 1.1727 | 1.0853 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.0033333 | 85.64 | 770.25 | 12726 | 12287 | 1.0357 | 1.0176 | MN20160304_L02 | C18 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.01 | 82.69 | 771.67 | 12734 | 11974 | 1.0635 | 1.0314 | MN20160304_L01 | J11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 73.76 | 771.67 | 12738 | 10851 | 1.1738 | 1.0858 | MN20160304_L01 | J13 |
| MCF 10A-H2B-mCherry | Alpelisib | 0.031667 | 87.14 | 771.67 | 12741 | 12592 | 1.0118 | 1.0058 | MN20160304_L01 | K22 |
| MCF 10A-H2B-mCherry | 0 | 80.48 | 771.67 | 12745 | 11685 | 1.0907 | 1.0448 | MN20160304_L01 | F16 | |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 78.25 | 771.67 | 12749 | 11367 | 1.1215 | 1.0600 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Etoposide | 0.01 | 83.42 | 770.25 | 12750 | 12031 | 1.0597 | 1.0295 | MN20160304_L02 | H16 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.17783 | 74.50 | 770.25 | 12752 | 10991 | 1.1602 | 1.0790 | MN20160304_L02 | J13 |
| MCF 10A-H2B-mCherry | 0 | 78.25 | 771.67 | 12755 | 11367 | 1.1220 | 1.0602 | MN20160304_L01 | K16 | |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 87.86 | 770.25 | 12757 | 12543 | 1.0170 | 1.0084 | MN20160304_L02 | E12 |